CAS: 1931944-80-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Donanemab REF: TM-T77162CAS: 1931944-80-7 | 95% | 216,00 €~2.460,00 € | Mar 04 Mar 25 |
 | Donanemab REF: 3D-CLA1552CAS: 1931944-80-7 | - - - | - - - | Producto descatalogado |
Donanemab
CAS:1931944-80-7
Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.
Pureza:
95%
Forma y color:
Liquid
Ref: TM-T77162
| 1mg | 216,00 € | ||
| 5mg | 560,00 € | ||
| 10mg | 912,00 € | ||
| 25mg | 1.349,00 € | ||
| 50mg | 1.825,00 € | ||
| 100mg | 2.460,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
Donanemab
CAS:1931944-80-7
A humanized IgG1 monoclonal antibody targets Aβ N-terminal epitope (p3-42).
Ref: 3D-CLA1552
| Tamaño no definido | Descatalogado | Solicitar información |
